The Center for Discovery and Innovation (CDI) is recruiting an Animal Technician Specialist with strong in vivo expertise to support drug discovery programs under the supervision of Matthew Zimmerman and Véronique Dartois. At CDI, you will play a hands-on role in the fight against some of the world’s most challenging infectious diseases — including tuberculosis, multidrug-resistant bacteria, and virusesof pandemic concern. As part of a collaborative, mission-focused team, you’ll contribute directly to preclinical drug discovery programs that aim to save lives globally.
The Animal Technician Specialist will assist with:
● Drug profiling pharmacokinetics (PK) in rodents and drug toxicity/tolerability studies.
● Drug efficacy models in rodents for multiple biosafety level pathogens (ABSL-2 and ABSL-3), including Mycobacterium species, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, followed by drug treatment and efficacy evaluation.
Additional responsibilities include organ homogenization and plating, agar plate preparation, organprocessing for histology (formalin fixation, slicing, H&E staining, and slide scanning), and data
collection and animal monitoring. A strong commitment to animal welfare, biosafety, and ethicalresearch conduct is essential.
The Center for Discovery and Innovation- CDI was established by Hackensack Meridian Health (HMH) as an academic basic and translational research enterprise to rapidly translate science innovation to the clinic and to improve outcomes for patients with cancer, infectious diseases, autoimmune disease and other acute and chronic diseases. The CDI has grown rapidly since its origins in 2019, and now has 32 labs, 190 scientists and allied personnel supported by 60 NIH grants and more than 30 other grants and contracts. Areas of expertise include genomics, epigenetics, drug resistance, immunology and immunotherapy, stem cell biology, drug discovery, diagnostics and biomarker development, and pharmacology.
